BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35405272)

  • 1. Pancreatic ductal adenocarcinoma cells employ integrin α6β4 to form hemidesmosomes and regulate cell proliferation.
    Humphries JD; Zha J; Burns J; Askari JA; Below CR; Chastney MR; Jones MC; Mironov A; Knight D; O'Reilly DA; Dunne MJ; Garrod DR; Jorgensen C; Humphries MJ
    Matrix Biol; 2022 Jun; 110():16-39. PubMed ID: 35405272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PYK2 Is Involved in Premalignant Acinar Cell Reprogramming and Pancreatic Ductal Adenocarcinoma Maintenance by Phosphorylating β-Catenin
    Gao C; Chen G; Zhang DH; Zhang J; Kuan SF; Hu W; Esni F; Gao X; Guan JL; Chu E; Hu J
    Cell Mol Gastroenterol Hepatol; 2019; 8(4):561-578. PubMed ID: 31330317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-Associated Fibroblast Induces Acinar-to-Ductal Cell Transdifferentiation and Pancreatic Cancer Initiation Via LAMA5/ITGA4 Axis.
    Parte S; Kaur AB; Nimmakayala RK; Ogunleye AO; Chirravuri R; Vengoji R; Leon F; Nallasamy P; Rauth S; Alsafwani ZW; Lele S; Cox JL; Bhat I; Singh S; Batra SK; Ponnusamy MP
    Gastroenterology; 2024 May; 166(5):842-858.e5. PubMed ID: 38154529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma.
    Lee AYL; Dubois CL; Sarai K; Zarei S; Schaeffer DF; Sander M; Kopp JL
    Gut; 2019 Mar; 68(3):487-498. PubMed ID: 29363536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer.
    Zhou H; Qin Y; Ji S; Ling J; Fu J; Zhuang Z; Fan X; Song L; Yu X; Chiao PJ
    Oncogene; 2018 Feb; 37(7):912-923. PubMed ID: 29059173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keratinocytes display normal proliferation, survival and differentiation in conditional beta4-integrin knockout mice.
    Raymond K; Kreft M; Janssen H; Calafat J; Sonnenberg A
    J Cell Sci; 2005 Mar; 118(Pt 5):1045-60. PubMed ID: 15731010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of nectin-like molecule 2 with integrin alpha6beta4 and inhibition of disassembly of integrin alpha6beta4 from hemidesmosomes.
    Mizutani K; Kawano S; Minami A; Waseda M; Ikeda W; Takai Y
    J Biol Chem; 2011 Oct; 286(42):36667-76. PubMed ID: 21880726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of hemidesmosome dynamics and cell signaling by integrin α6β4.
    Te Molder L; de Pereda JM; Sonnenberg A
    J Cell Sci; 2021 Sep; 134(18):. PubMed ID: 34523678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase Cdelta-mediated phosphorylation of alpha6beta4 is associated with reduced integrin localization to the hemidesmosome and decreased keratinocyte attachment.
    Alt A; Ohba M; Li L; Gartsbein M; Belanger A; Denning MF; Kuroki T; Yuspa SH; Tennenbaum T
    Cancer Res; 2001 Jun; 61(11):4591-8. PubMed ID: 11389095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of the alpha6beta4 integrin in keratinocytes.
    Geuijen CA; Sonnenberg A
    Mol Biol Cell; 2002 Nov; 13(11):3845-58. PubMed ID: 12429829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer.
    Zhang S; Chung WC; Xu K
    Oncogene; 2016 May; 35(19):2485-95. PubMed ID: 26279302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
    Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
    Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progression.
    Li Z; Shao C; Liu X; Lu X; Jia X; Zheng X; Wang S; Zhu L; Li K; Pang Y; Xie F; Lu Y; Wang Y
    Carcinogenesis; 2020 Mar; 41(1):44-55. PubMed ID: 31046123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Tongue Squamous Carcinoma Cell Line Cal27 Primarily Employs Integrin α6β4-Containing Type II Hemidesmosomes for Adhesion Which Contribute to Anticancer Drug Sensitivity.
    Tadijan A; Humphries JD; Samaržija I; Stojanović N; Zha J; Čuljak K; Tomić M; Paradžik M; Nestić D; Kang H; Humphries MJ; Ambriović-Ristov A
    Front Cell Dev Biol; 2021; 9():786758. PubMed ID: 34977030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer.
    Singh K; Pruski M; Bland R; Younes M; Guha S; Thosani N; Maitra A; Cash BD; McAllister F; Logsdon CD; Chang JT; Bailey-Lundberg JM
    Lab Invest; 2021 Feb; 101(2):177-192. PubMed ID: 33009500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pancreatic cancer organoid platform identifies an inhibitor specific to mutant KRAS.
    Duan X; Zhang T; Feng L; de Silva N; Greenspun B; Wang X; Moyer J; Martin ML; Chandwani R; Elemento O; Leach SD; Evans T; Chen S; Pan FC
    Cell Stem Cell; 2024 Jan; 31(1):71-88.e8. PubMed ID: 38151022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCAT2-mediated BCAA catabolism is critical for development of pancreatic ductal adenocarcinoma.
    Li JT; Yin M; Wang D; Wang J; Lei MZ; Zhang Y; Liu Y; Zhang L; Zou SW; Hu LP; Zhang ZG; Wang YP; Wen WY; Lu HJ; Chen ZJ; Su D; Lei QY
    Nat Cell Biol; 2020 Feb; 22(2):167-174. PubMed ID: 32029896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The acinar regulator Gata6 suppresses KrasG12V-driven pancreatic tumorigenesis in mice.
    Martinelli P; Madriles F; Cañamero M; Pau EC; Pozo ND; Guerra C; Real FX
    Gut; 2016 Mar; 65(3):476-86. PubMed ID: 25596178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANGPTL4 accelerates KRAS
    Yan HH; Jung KH; Lee JE; Son MK; Fang Z; Park JH; Kim SJ; Kim JY; Lim JH; Hong SS
    Cancer Lett; 2021 Oct; 519():185-198. PubMed ID: 34311032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.